Dr. Reddy's expands strategic collaboration with Amgen

16 Sep 2016 Evaluate

Dr. Reddy's Laboratories has expanded strategic collaboration with Amgen, one of the world's leading independent biotechnology companies, to market and distribute three of Amgen's medicines in India in the therapy areas of oncology and osteoporosis. Under the terms of the collaboration, the company will commercialise XGEVA'(denosumab), Vectibix' (panitumumab) and Prolia (donosumab) in India.

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.

Dr. Reddys Lab Share Price

1272.85 -6.75 (-0.53%)
19-Dec-2025 14:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1746.20
Dr. Reddys Lab 1272.85
Cipla 1511.90
Zydus Lifesciences 918.05
Lupin 2124.60
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×